Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Identification of a New α-Synuclein Aggregation Inhibitor via Mass Spectrometry Based Screening.

Xu M, Loa-Kum-Cheung W, Zhang H, Quinn RJ, Mellick GD.

ACS Chem Neurosci. 2019 Jun 19;10(6):2683-2691. doi: 10.1021/acschemneuro.9b00092. Epub 2019 Jun 4.

PMID:
31117342
2.

O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.

Ryan P, Xu M, Davey AK, Danon JJ, Mellick GD, Kassiou M, Rudrawar S.

ACS Chem Neurosci. 2019 May 15;10(5):2209-2221. doi: 10.1021/acschemneuro.9b00143. Epub 2019 Apr 26.

PMID:
30985105
3.

Depression symptomatology correlates with event-related potentials in Parkinson's disease: An affective priming study.

Dissanayaka NNW, Au TR, Angwin AJ, Iyer KK, O'Sullivan JD, Byrne GJ, Silburn PA, Marsh R, Mellick GD, Copland DA.

J Affect Disord. 2019 Feb 15;245:897-904. doi: 10.1016/j.jad.2018.11.094. Epub 2018 Nov 13.

PMID:
30699874
4.

Wild-type and mutant (G2019S) leucine-rich repeat kinase 2 (LRRK2) associate with subunits of the translocase of outer mitochondrial membrane (TOM) complex.

Neethling A, Engelbrecht L, Loos B, Kinnear C, Theart R, Abrahams S, Niesler T, Mellick GD, Williams M, Bardien S.

Exp Cell Res. 2019 Feb 15;375(2):72-79. doi: 10.1016/j.yexcr.2018.12.022. Epub 2018 Dec 28.

PMID:
30597143
5.

Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females.

Loesch DZ, Tassone F, Mellick GD, Horne M, Rubio JP, Bui MQ, Francis D, Storey E.

Mov Disord. 2018 Jul;33(7):1178-1181. doi: 10.1002/mds.27420.

6.

How Well Do Caregivers Detect Depression and Anxiety in Patients With Parkinson Disease?

Kua ZJ, Pachana NA, Byrne GJ, O'Sullivan JD, Marsh R, Torbey E, Silburn PA, Mellick GD, Dissanayaka NNW.

J Geriatr Psychiatry Neurol. 2018 Sep;31(5):227-236. doi: 10.1177/0891988718788641. Epub 2018 Aug 2.

PMID:
30071791
7.

Design and Synthesis of Natural Product Inspired Libraries Based on the Three-Dimensional (3D) Cedrane Scaffold: Toward the Exploration of 3D Biological Space.

Mazraati Tajabadi F, Pouwer RH, Liu M, Dashti Y, Campitelli MR, Murtaza M, Mellick GD, Wood SA, Jenkins ID, Quinn RJ.

J Med Chem. 2018 Aug 9;61(15):6609-6628. doi: 10.1021/acs.jmedchem.8b00194. Epub 2018 Jul 27.

8.

Pipeline to gene discovery - Analysing familial Parkinsonism in the Queensland Parkinson's Project.

Bentley SR, Bortnick S, Guella I, Fowdar JY, Silburn PA, Wood SA, Farrer MJ, Mellick GD.

Parkinsonism Relat Disord. 2018 Apr;49:34-41. doi: 10.1016/j.parkreldis.2017.12.033. Epub 2018 Jan 3.

PMID:
29329938
9.

Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson's disease.

Chan DKY, Xu YH, Chan LKM, Braidy N, Mellick GD.

Transl Neurodegener. 2017 Dec 20;6:33. doi: 10.1186/s40035-017-0104-6. eCollection 2017. Review.

10.

Dexamethasone Inhibits Copper-Induced Alpha-Synuclein Aggregation by a Metallothionein-Dependent Mechanism.

McLeary FA, Rcom-H'cheo-Gauthier AN, Kinder J, Goulding M, Khoo TK, Mellick GD, Chung RS, Pountney DL.

Neurotox Res. 2018 Feb;33(2):229-238. doi: 10.1007/s12640-017-9825-7. Epub 2017 Oct 24.

PMID:
29064068
11.

Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder.

Puschmann A, Fiesel FC, Caulfield TR, Hudec R, Ando M, Truban D, Hou X, Ogaki K, Heckman MG, James ED, Swanberg M, Jimenez-Ferrer I, Hansson O, Opala G, Siuda J, Boczarska-Jedynak M, Friedman A, Koziorowski D, Rudzinska-Bar M, Aasly JO, Lynch T, Mellick GD, Mohan M, Silburn PA, Sanotsky Y, Vilariño-Güell C, Farrer MJ, Chen L, Dawson VL, Dawson TM, Wszolek ZK, Ross OA, Springer W.

Brain. 2017 Jun 1;140(6):e33. doi: 10.1093/brain/awx077. No abstract available.

12.

Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease.

Butcher NJ, Horne MK, Mellick GD, Fowler CJ, Masters CL; AIBL research group, Minchin RF.

Pharmacogenomics J. 2018 Apr;18(2):209-214. doi: 10.1038/tpj.2017.4. Epub 2017 Apr 4.

PMID:
28374858
13.

N400 and emotional word processing in Parkinson's disease.

Dissanayaka NNW, Au TR, Angwin AJ, O'Sullivan JD, Byrne GJ, Silburn PA, Marsh R, Mellick GD, Copland DA.

Neuropsychology. 2017 Sep;31(6):585-595. doi: 10.1037/neu0000333. Epub 2017 Mar 13.

PMID:
28287777
14.

Role of the VPS35 D620N mutation in Parkinson's disease.

Mohan M, Mellick GD.

Parkinsonism Relat Disord. 2017 Mar;36:10-18. doi: 10.1016/j.parkreldis.2016.12.001. Epub 2016 Dec 5. Review.

PMID:
27964832
15.

Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study.

Wang L, Heckman MG, Aasly JO, Annesi G, Bozi M, Chung SJ, Clarke C, Crosiers D, Eckstein G, Garraux G, Hadjigeorgiou GM, Hattori N, Jeon B, Kim YJ, Kubo M, Lesage S, Lin JJ, Lynch T, Lichtner P, Mellick GD, Mok V, Morrison KE, Quattrone A, Satake W, Silburn PA, Stefanis L, Stockton JD, Tan EK, Toda T, Brice A, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Maraganore DM, Gasser T, Krüger R, Farrer MJ, Ross OA, Sharma M; GEOPD Consortium.

Neurobiol Aging. 2017 Jan;49:217.e1-217.e4. doi: 10.1016/j.neurobiolaging.2016.09.022. Epub 2016 Oct 6.

16.

Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism.

Puschmann A, Fiesel FC, Caulfield TR, Hudec R, Ando M, Truban D, Hou X, Ogaki K, Heckman MG, James ED, Swanberg M, Jimenez-Ferrer I, Hansson O, Opala G, Siuda J, Boczarska-Jedynak M, Friedman A, Koziorowski D, Rudzińska-Bar M, Aasly JO, Lynch T, Mellick GD, Mohan M, Silburn PA, Sanotsky Y, Vilariño-Güell C, Farrer MJ, Chen L, Dawson VL, Dawson TM, Wszolek ZK, Ross OA, Springer W.

Brain. 2017 Jan;140(1):98-117. doi: 10.1093/brain/aww261. Epub 2016 Nov 2. Erratum in: Brain. 2017 Jun 1;140(6):e37.

17.

Meeting the Challenge: Using Cytological Profiling to Discover Chemical Probes from Traditional Chinese Medicines against Parkinson's Disease.

Wang C, Yang X, Mellick GD, Feng Y.

ACS Chem Neurosci. 2016 Dec 21;7(12):1628-1634. doi: 10.1021/acschemneuro.6b00245. Epub 2016 Oct 26. Review.

PMID:
27736095
18.

A Grand Challenge. 2. Phenotypic Profiling of a Natural Product Library on Parkinson's Patient-Derived Cells.

Vial ML, Zencak D, Grkovic T, Gorse AD, Mackay-Sim A, Mellick GD, Wood SA, Quinn RJ.

J Nat Prod. 2016 Aug 26;79(8):1982-9. doi: 10.1021/acs.jnatprod.6b00258. Epub 2016 Jul 22.

19.

Identification of genetic modifiers of age-at-onset for familial Parkinson's disease.

Hill-Burns EM, Ross OA, Wissemann WT, Soto-Ortolaza AI, Zareparsi S, Siuda J, Lynch T, Wszolek ZK, Silburn PA, Mellick GD, Ritz B, Scherzer CR, Zabetian CP, Factor SA, Breheny PJ, Payami H.

Hum Mol Genet. 2016 Sep 1;25(17):3849-3862. doi: 10.1093/hmg/ddw206. Epub 2016 Jul 11.

20.

A door-to-door survey to estimate the prevalence of Parkinsonism in Pakistan.

Khan S, Nabi G, Naeem M, Ali L, Silburn PA, Mellick GD.

Neuropsychiatr Dis Treat. 2016 Jun 21;12:1499-506. doi: 10.2147/NDT.S86329. eCollection 2016.

21.

Nrf2: a modulator of Parkinson's disease?

Todorovic M, Wood SA, Mellick GD.

J Neural Transm (Vienna). 2016 Jun;123(6):611-9. doi: 10.1007/s00702-016-1563-0. Epub 2016 May 4. Review.

PMID:
27145762
22.

Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson's Disease.

Murtaza M, Shan J, Matigian N, Todorovic M, Cook AL, Ravishankar S, Dong LF, Neuzil J, Silburn P, Mackay-Sim A, Mellick GD, Wood SA.

PLoS One. 2016 Apr 28;11(4):e0154544. doi: 10.1371/journal.pone.0154544. eCollection 2016.

23.

Disease-specific anxiety symptomatology in Parkinson's disease.

Dissanayaka NN, O'Sullivan JD, Pachana NA, Marsh R, Silburn PA, White EX, Torbey E, Mellick GD, Copland DA, Byrne GJ.

Int Psychogeriatr. 2016 Jul;28(7):1153-63. doi: 10.1017/S1041610215002410. Epub 2016 Feb 10.

PMID:
26861614
24.

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.

Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschländer A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjigeorgiou GM, Hicks AA, Hattori N, Klein C, Jeon B, Kim YJ, Lesage S, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pihlstrøm L, Pramstaller PP, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Silburn PA, Theuns J, Tan EK, Tomiyama H, Toft M, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore DM, Krüger R, Sharma M; GEO-PD Consortium.

Neurology. 2015 Oct 13;85(15):1283-92. doi: 10.1212/WNL.0000000000002016. Epub 2015 Sep 9.

25.

Comprehensive assessment of genetic sequence variants in the antioxidant 'master regulator' NRF2 in idiopathic Parkinson's disease.

Todorovic M, Newman JR, Shan J, Bentley S, Wood SA, Silburn PA, Mellick GD.

PLoS One. 2015 May 26;10(5):e0128030. doi: 10.1371/journal.pone.0128030. eCollection 2015.

26.

Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease.

Dissanayaka NNW, White E, O'Sullivan JD, Marsh R, Silburn PA, Copland DA, Mellick GD, Byrne GJ.

Mov Disord Clin Pract. 2015 Apr 6;2(2):155-162. doi: 10.1002/mdc3.12157. eCollection 2015 Jun.

27.

Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology.

Wilson GR, Sim JC, McLean C, Giannandrea M, Galea CA, Riseley JR, Stephenson SE, Fitzpatrick E, Haas SA, Pope K, Hogan KJ, Gregg RG, Bromhead CJ, Wargowski DS, Lawrence CH, James PA, Churchyard A, Gao Y, Phelan DG, Gillies G, Salce N, Stanford L, Marsh AP, Mignogna ML, Hayflick SJ, Leventer RJ, Delatycki MB, Mellick GD, Kalscheuer VM, D'Adamo P, Bahlo M, Amor DJ, Lockhart PJ.

Am J Hum Genet. 2014 Dec 4;95(6):729-35. doi: 10.1016/j.ajhg.2014.10.015. Epub 2014 Nov 26.

28.

Improved nutritional status is related to improved quality of life in Parkinson's disease.

Sheard JM, Ash S, Mellick GD, Silburn PA, Kerr GK.

BMC Neurol. 2014 Nov 18;14:212. doi: 10.1186/s12883-014-0212-1.

29.

Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease.

Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Smolders S, Crosiers D, Corsmit E, Elinck E, Sharma M, Krüger R, Lesage S, Brice A, Chung SJ, Kim MJ, Kim YJ, Ross OA, Wszolek ZK, Rogaeva E, Xi Z, Lang AE, Klein C, Weissbach A, Mellick GD, Silburn PA, Hadjigeorgiou GM, Dardiotis E, Hattori N, Ogaki K, Tan EK, Zhao Y, Aasly J, Valente EM, Petrucci S, Annesi G, Quattrone A, Ferrarese C, Brighina L, Deutschländer A, Puschmann A, Nilsson C, Garraux G, LeDoux MS, Pfeiffer RF, Boczarska-Jedynak M, Opala G, Maraganore DM, Engelborghs S, De Deyn PP, Cras P, Cruts M, Van Broeckhoven C; GEO-PD Consortium.

Neurology. 2014 Nov 18;83(21):1906-13. doi: 10.1212/WNL.0000000000001012. Epub 2014 Oct 17.

30.

Risk factors for idiopathic dystonia in Queensland, Australia.

Newman JR, Boyle RS, O'Sullivan JD, Silburn PA, Mellick GD.

J Clin Neurosci. 2014 Dec;21(12):2145-9. doi: 10.1016/j.jocn.2014.03.032. Epub 2014 Jul 28.

PMID:
25082409
31.

NMR fingerprints of the drug-like natural-product space identify iotrochotazine A: a chemical probe to study Parkinson's disease.

Grkovic T, Pouwer RH, Vial ML, Gambini L, Noël A, Hooper JN, Wood SA, Mellick GD, Quinn RJ.

Angew Chem Int Ed Engl. 2014 Jun 10;53(24):6070-4. doi: 10.1002/anie.201402239. Epub 2014 Apr 15.

32.

Lack of reproducibility in re-evaluating associations between GCH1 polymorphisms and Parkinson's disease and isolated dystonia in an Australian case--control group.

Newman JR, Todorovic M, Silburn PA, Sutherland GT, Mellick GD.

Parkinsonism Relat Disord. 2014 Jun;20(6):668-70. doi: 10.1016/j.parkreldis.2014.02.014. Epub 2014 Mar 12. No abstract available.

PMID:
24674769
33.

Rare POLG1 CAG variants do not influence Parkinson's disease or polymerase gamma function.

Bentley SR, Shan J, Todorovic M, Wood SA, Mellick GD.

Mitochondrion. 2014 Mar;15:65-8. doi: 10.1016/j.mito.2014.01.004. Epub 2014 Jan 31.

PMID:
24491464
34.

DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro.

Coupland KG, Mellick GD, Silburn PA, Mather K, Armstrong NJ, Sachdev PS, Brodaty H, Huang Y, Halliday GM, Hallupp M, Kim WS, Dobson-Stone C, Kwok JB.

Mov Disord. 2014 Nov;29(13):1606-14. doi: 10.1002/mds.25784. Epub 2013 Dec 27. Erratum in: Mov Disord. 2016 May;31(5):768.

35.

The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer.

Follett J, Norwood SJ, Hamilton NA, Mohan M, Kovtun O, Tay S, Zhe Y, Wood SA, Mellick GD, Silburn PA, Collins BM, Bugarcic A, Teasdale RD.

Traffic. 2014 Feb;15(2):230-44. doi: 10.1111/tra.12136. Epub 2013 Nov 14.

36.

Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Rhodes SL, Buchanan DD, Ahmed I, Taylor KD, Loriot MA, Sinsheimer JS, Bronstein JM, Elbaz A, Mellick GD, Rotter JI, Ritz B.

Neurobiol Dis. 2014 Feb;62:172-8. doi: 10.1016/j.nbd.2013.09.019. Epub 2013 Oct 8.

37.

Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

Heckman MG, Elbaz A, Soto-Ortolaza AI, Serie DJ, Aasly JO, Annesi G, Auburger G, Bacon JA, Boczarska-Jedynak M, Bozi M, Brighina L, Chartier-Harlin MC, Dardiotis E, Destée A, Ferrarese C, Ferraris A, Fiske B, Gispert S, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lin CH, Lohmann K, Loriot MA, Lynch T, Mellick GD, Mutez E, Opala G, Park SS, Petrucci S, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Tomiyama H, Uitti RJ, Valente EM, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Xiromerisiou G, Maraganore DM, Farrer MJ, Ross OA; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.

Neurobiol Aging. 2014 Jan;35(1):266.e5-14. doi: 10.1016/j.neurobiolaging.2013.07.013. Epub 2013 Aug 17.

38.

Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Heckman MG, Soto-Ortolaza AI, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Boczarska-Jedynak M, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lesage S, Lin CH, Lynch T, Maraganore DM, Mellick GD, Mutez E, Nilsson C, Opala G, Park SS, Petrucci S, Puschmann A, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Theuns J, Tomiyama H, Uitti RJ, Valente EM, Van Broeckhoven C, van de Loo S, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Hentati F, Farrer MJ, Ross OA; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Mov Disord. 2013 Oct;28(12):1740-4. doi: 10.1002/mds.25600. Epub 2013 Aug 2.

39.

Screening for rare sequence variants in the THAP1 gene in a primary dystonia cohort.

Newman JR, Lehn AC, Boyle RS, Silburn PA, Mellick GD.

Mov Disord. 2013 Oct;28(12):1752-3. doi: 10.1002/mds.25479. Epub 2013 May 6. No abstract available.

PMID:
23649788
40.

Markers of disease severity are associated with malnutrition in Parkinson's disease.

Sheard JM, Ash S, Mellick GD, Silburn PA, Kerr GK.

PLoS One. 2013;8(3):e57986. doi: 10.1371/journal.pone.0057986. Epub 2013 Mar 27.

41.

Malnutrition in a sample of community-dwelling people with Parkinson's disease.

Sheard JM, Ash S, Mellick GD, Silburn PA, Kerr GK.

PLoS One. 2013;8(1):e53290. doi: 10.1371/journal.pone.0053290. Epub 2013 Jan 9.

42.

New evidence for, and challenges in, linking small CGG repeat expansion FMR1 alleles with Parkinson's disease.

Loesch DZ, Tassone F, Lo J, Slater HR, Hills LV, Bui MQ, Silburn PA, Mellick GD.

Clin Genet. 2013 Oct;84(4):382-5. doi: 10.1111/cge.12070. Epub 2012 Dec 25.

PMID:
23198693
43.

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Bertram L, Bozi M, Barcikowska M, Crosiers D, Clarke CE, Facheris MF, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon BS, Jamrozik Z, Krygowska-Wajs A, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Libioulle C, Murata M, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Meitnger T, Zimprich A, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Strom TM, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Van Broeckhoven C, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yomono HS, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEOPD consortium.

J Med Genet. 2012 Nov;49(11):721-6. doi: 10.1136/jmedgenet-2012-101155. Erratum in: J Med Genet. 2013 Mar;50(3):202.

44.

Large-scale replication and heterogeneity in Parkinson disease genetic loci.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Van Broeckhoven C, Bertram L, Bozi M, Crosiers D, Clarke C, Facheris M, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon B, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEO-PD Consortium.

Neurology. 2012 Aug 14;79(7):659-67. doi: 10.1212/WNL.0b013e318264e353. Epub 2012 Jul 11.

45.

Validity and reliability of the Geriatric Anxiety Inventory in Parkinson's disease.

Matheson SF, Byrne GJ, Dissanayaka NN, Pachana NA, Mellick GD, O'Sullivan JD, Silburn PA, Sellbach A, Marsh R.

Australas J Ageing. 2012 Mar;31(1):13-6. doi: 10.1111/j.1741-6612.2010.00487.x. Epub 2010 Dec 29.

PMID:
22417148
46.

Common polymorphisms in dystonia-linked genes and susceptibility to the sporadic primary dystonias.

Newman JR, Sutherland GT, Boyle RS, Limberg N, Blum S, O'Sullivan JD, Silburn PA, Mellick GD.

Parkinsonism Relat Disord. 2012 May;18(4):351-7. doi: 10.1016/j.parkreldis.2011.11.024. Epub 2011 Dec 14.

PMID:
22172551
47.

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Van Broeckhoven C, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Ferraris A, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lesage S, Lin CH, Lynch T, Maraganore DM, Mellick GD, Mutez E, Nilsson C, Opala G, Park SS, Puschmann A, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Theuns J, Tomiyama H, Uitti RJ, Valente EM, van de Loo S, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Farrer MJ; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.

Lancet Neurol. 2011 Oct;10(10):898-908. doi: 10.1016/S1474-4422(11)70175-2. Epub 2011 Aug 30. Erratum in: Lancet Neurol. 2011 Oct;10(10):870.

48.

Variance of gene expression identifies altered network constraints in neurological disease.

Mar JC, Matigian NA, Mackay-Sim A, Mellick GD, Sue CM, Silburn PA, McGrath JJ, Quackenbush J, Wells CA.

PLoS Genet. 2011 Aug;7(8):e1002207. doi: 10.1371/journal.pgen.1002207. Epub 2011 Aug 11.

49.

Single and dual task gait training in people with Parkinson's disease: a protocol for a randomised controlled trial.

Brauer SG, Woollacott MH, Lamont R, Clewett S, O'Sullivan J, Silburn P, Mellick GD, Morris ME.

BMC Neurol. 2011 Jul 27;11:90. doi: 10.1186/1471-2377-11-90.

50.

Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease.

Sharma M, Maraganore DM, Ioannidis JP, Riess O, Aasly JO, Annesi G, Abahuni N, Bentivoglio AR, Brice A, Van Broeckhoven C, Chartier-Harlin MC, Destée A, Djarmati A, Elbaz A, Farrer M, Ferrarese C, Gibson JM, Gispert S, Hattori N, Jasinska-Myga B, Klein C, Lesage S, Lynch T, Lichtner P, Lambert JC, Lang AE, Mellick GD, De Nigris F, Opala G, Quattrone A, Riva C, Rogaeva E, Ross OA, Satake W, Silburn PA, Theuns J, Toda T, Tomiyama H, Uitti RJ, Wirdefeldt K, Wszolek Z, Gasser T, Krüger R; Genetic Epidemiology of Parkinson's Disease Consortium.

Neurobiol Aging. 2011 Nov;32(11):2108.e1-5. doi: 10.1016/j.neurobiolaging.2011.05.024. Epub 2011 Jul 22.

PMID:
21782285

Supplemental Content

Loading ...
Support Center